EU and UK, Allow 3-5 Working Days For Delivery

FDA Peptide Review Results: 6 Out of 7 Peptide Pass

On 23 and 24 July 2025, the FDA’s Pharmacy Compounding Advisory Committee (PCAC) convened to review seven peptide-related compounds being considered for potential inclusion on the 503A Bulks List. After two days of discussion, six of the seven received positive recommendations from the committee. One did not. For a field that has operated in a

What Is NAD+ and Why Is It Not a Peptide?

NAD+ appears regularly in discussions about longevity, cellular energy, and metabolic health research, often alongside peptides and other compounds associated with the same field. This proximity can create the impression that NAD+ belongs to the same category. However, NAD+ is not a peptide, it is a distinct class of molecule with a different chemical structure,

Why is BPC-157 and TB-500 a popular blend?

In tissue repair and musculoskeletal peptide research, few compound combinations appear as consistently as BPC-157 and TB-500. The two are studied individually for well-characterised mechanisms, and they are frequently discussed together because their biological effects overlap and complement each other in ways that make the pairing scientifically coherent rather than random. What Is BPC-157? BPC-157

The Evolution of Peptides (Peptide History and Timeline)

When people encounter Peptide Therapy research for the first time, it can seem like a recent development, especially with the new “boom” online. The history of peptides in scientific research stretches back well over a century, with roots in some of the most significant discoveries in the entire history of medicine. Peptide signalling is not

Why You Should Know About Heart Bioregulators (Chelohart)

Cardiovascular science is one of the most extensively researched areas in medicine. Within it, a relatively niche but scientifically distinct field has developed over several decades: the study of heart bioregulators. Heart bioregulators are short peptide complexes derived from cardiac tissue and are studied for their role in cardiac gene expression and cardiomyocyte (heart muscle

The Different Peptide Formats, Explained

When people first encounter Peptide Therapy research, the format a compound comes in can seem like a practical detail rather than a scientific one.  The route of administration changes where in the body a peptide can reach, how much of it enters circulation, and which biological systems it is positioned to interact with. The two

Peptides Studied in Women’s Health Research

Women’s physiology involves a set of hormonal and biological processes that shift considerably across different life stages. From the mid-thirties onward, these shifts begin to influence several interconnected systems simultaneously, including skin biology, connective tissue integrity, sleep regulation, stress resilience, and cognitive function. Research into women’s health peptides has grown alongside a broader interest in

What the Nootropic Industry Gets Wrong About Brain Health

When people describe what they want from a nootropic, the answer tends to be some combination of greater focus, sharper memory, and the ability to keep performing when concentration starts to fade. These are reasonable goals, and the most common way of pursuing them involves stimulating the brain’s existing chemistry to produce more output in

Why MOTS-c Is called “Exercise in a Bottle”

When you exercise, something remarkable happens inside your muscle cells. Beyond the familiar burn and the breathlessness, your mitochondria begin producing a small signalling molecule called MOTS-c. MOTS-c is a peptide that has been described by researchers as one of the reasons exercise is so beneficial at a cellular level. What makes MOTS-c especially intriguing

Why Every Successful Peptide Cycle Is Built Around Knowing When to Stop

There is a question that does not get enough clarification in peptide research discussions: what is the endpoint? What does success look like, and when does the protocol end? The answer, for most people researching Peptide Therapy responsibly, is that the endpoint is the point at which the body no longer needs the same level

Select your currency

Are you over 21 years of age?​

You are not old enough to view this content